I-Mab Announces Participation at Jefferies and Piper Conferences in November
ROCKVILLE, Md. and
Presentation Time |
|
Presenters |
Mr. |
Webcast link |
https://wsw.com/webcast/jeff287/imab/1828028 |
Meetings |
One-on-one and small group meetings: Nov 14 – 16, 2023 |
Management |
Mr. |
For more information, please contact your Jefferies representative.
Piper Sandler 35th Annual Healthcare Conference (In Person)
Presentation Time |
|
Presenters |
Mr. |
Meetings |
One-on-one and small group meetings: |
Management |
Mr. |
For more information, please contact your Piper Sandler representative.
About I-Mab
I-Mab (Nasdaq: IMAB) is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics. I-Mab's innovative pipeline is driven by internal R&D's Fast-to-Proof-of-Concept, Fast-to-Market development strategies, and through global partnerships. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn, X, formerly known as Twitter, and WeChat.
I-Mab Contacts
Investors |
Media |
|
|
Senior Director, Investor Relations |
Chief Communications Officer |
View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-announces-participation-at-jefferies-and-piper-conferences-in-november-301978319.html
SOURCE